Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Boniuk's investment is death spiral financing? Do I really need to point out the ridiculousness of that statement? So I guess he subsequently bought stock on the open market because he's funding the company into a death spiral. That's a good one. There are some good primers on these things I can point you to that will relieve you of that gross misconception.
for about the 5th time, they spent that year scaling the process so that now they are able to do batches of 200g.
gladly,
NanoViricides Reports that its Director Dr. Milton Boniuk, a Director, Has Invested $5M into the Company in a Convertible Debenture
Published: July 2, 2014 7:00 a.m. ET
WEST HAVEN, Conn., Jul 02, 2014 (BUSINESS WIRE) -- NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”) reported today that Milton Boniuk, MD, the Caroline F. Elles Chair Professor of Ophthalmology at Baylor College of Medicine, and a Director of the Company, has invested $5M in the Company in the form of a convertible debenture (the “Debenture”).
Dr. Boniuk said that his confidence in the Company has only continued to grow as he sees the Company’s management and execution now from a closer perspective, in his role as a Director.
Professor Boniuk has also invested in the Company in earlier rounds of financing. The new financing brings the total financing provided by him to $12 Million to date. These investments were made both personally as well as from his charitable foundation and other interests. Professor Boniuk joined the Company’s Board as an independent director in May 2013, at the request of the Company’s executives.
“My belief that the Company’s potential is nothing short of amazing has only become stronger as I become more familiar with the Company’s technology, programs, and achievements,” said Dr. Boniuk when asked about his continuing investments into the Company.
And here is a link to the form 4 for the recent open market purchases that you seemed to miss,
http://archive.fast-edgar.com//20141020/AAAJ522CZZ22L2Z222TR22Z9CW48ZB22N262/
Gee, which is the more reliable indicator, an anonymous chat board poster? LOL
such a silly statement when you consider folks like Dr. Harris and USAMRIID recently signed up for a second round of testing with them. And when you have an insider that ponies up $12M.
what's really bizarre is someone who is not a bull yet owns the stock and spends so much time trashing it. Or at least that is what you would have us believe.
stock performance over the next 6 months will be determined primarily by developments at USAMRIID not tox on Flucide. But feel free to keep floating these strawman artificial self imposed deadlines.
and since it was clearly stated in filed documents and therefore widely known, it is already baked into the stock price as well.
It just shows the market makers are in on the attempted manipulation. That's the only way you get an actual print at $2.69. The 100K ask at $3.40 was there on Friday and probably done in coordination with the SA article and the bogus print for psychological reasons.
Wow, you still don't get it. Once the process is scaled, a batch can be run in a few weeks.
Apparently you are having trouble interpreting your own post. It says Phase I and IIa COMPLETED by Fall 2016. So of course it is ridiculous spin to say "2 more years before clinicals".
common sense?
He said -
No, he's referring to the recent open market purchases:
http://archive.fast-edgar.com//20141020/AAAJ522CZZ22L2Z222TR22Z9CW48ZB22N262/
Or of course you could realize that they have successfully scaled to 200g batches and could obviously meet the required amount by producing (and shipping) 2 batches per month going forward.
LOL, you do realize there is a difference between cGMP and cGMP-like? As stated, cGMP-like is required for human trials, full cGMP certification comes later.
you are equating the insight and information available to an insider to that of your run of the mill fund manager? Wow, ok.
You have interpreted incorrectly. They have successfully scaled the process so that they are now capable of producing batches of 200g going forward. Another scale up coming at the new facility. It did not take a year to produce 200g, but it did take most of the year to finish scaling the process to the point where they can now do batches in that quantity. Pretty simple, yes?
If you still don't get it, I give up.
You have interpreted incorrectly. They have successfully scaled the process so that they are now capable of producing batches of 200g going forward. Another scale up coming at the new facility. It did not take a year to produce 200g, but it did take most of the year to finish scaling the process to the point where they can now do batches in that quantity. Pretty simple, yes?
LOL how many times are you going to try to change the reference date of the post? It was written 1 month ago, not 1 year, not 3 months, not 9 yrs not any other number you can come up with. One month (30 days). ROTFL
Of course you wrote the post a month ago, not a year ago before ebola was even on anybody's radar.
45% differential in 1 month. Now that ebola is a current threat and candidates are being put forth and evaluated let's annualize that to see which one the market thinks is the bullshit company:
NNVC + 72%
TKMR - 456%
The market sure seems to think one of them is bullshit when it comes to an ebola treatment. And as we all know "Mr. Market can tell quite well".
as usual?? LOL.
TKMR down another 7% today. 1 month return -38%
vs.
NNVC +6% over the same period.
The market says when it comes to ebola, one of them is a "bullshit company"
and as we have been told, "Mr. market can tell a real drug company from a bullshit company quite well."
http://finance.yahoo.com/echarts?s=NNVC+Interactive#%7B%22range%22%3A%221mo%22%2C%22scale%22%3A%22linear%22%2C%22comparisons%22%3A%7B%22TKMR%22%3A%7B%22color%22%3A%22%23cc0000%22%2C%22weight%22%3A1%7D%7D%7D
right drkaz, the market is rendering its collective judgment on the relative prospects of the 2 ebola treatments in the here and now. It is clearly saying one is a bullshit company when it comes to treating ebola.
it's been exactly 1 month since the post below was made. What is relevant is what has transpired since that point in time, right? TKMR was then touted as a superior investment to NNVC, it's clearly been a disaster. 43% worse than NNVC as an investment over that time. Ugly.
Yep, awesome call.
LOL.
http://finance.yahoo.com/echarts?t=1m&s=TKMR&l=on&z=l&q=l&c=nnvc&ql=1
yes i would certainly agree, that is a 43% differential since your call. In favor of NNVC. The market doesn't appear to have any problem at all distinguishing between a company with potential and a crap company with severe safety issues. Guess we know where these companies are respectively headed.
speaking of spot on calls this chart was posted earlier comparing charts as you suggested -
http://finance.yahoo.com/echarts?t=1m&s=TKMR&l=on&z=l&q=l&c=nnvc&ql=1
just wondering if your thinking has changed on which one the market is saying is the bullshit company?
like I said it sounds like you are not understanding what a shelf filing is. It means no such thing, timing is TBD. A shelf is generally filed to insure funds can be raised if and when the company determines, at their discretion. Some companies file a shelf and never use it. I think in this case it is more likely that it gets tapped down the line after Ebolacide is substantially through development.
you are conflating the mere filing of a shelf with past deals with Seaside. Of course one does not presuppose the other. Having a shelf in place is simply good business practice. By the way if you will recall at the bottom you said the stock was going way lower, just before it launched about 6 fold. So how about a little reality check.
doesn't sound like you understand what filing a shelf actually means.
which is it, can't have it both ways.